Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic cannabinoids 2015: An update for pediatricians in clinical practice
Daniel Castellanos
World Journal of Clinical Pediatrics (2016) Vol. 5, Iss. 1, pp. 16-16
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues
Samuel D. Banister, Mitchell Longworth, Richard C. Kevin, et al.
ACS Chemical Neuroscience (2016) Vol. 7, Iss. 9, pp. 1241-1254
Closed Access | Times Cited: 232
Cannabis, cannabinoids, and health
Geneviève Lafaye, Laurent Karila, Lisa Blecha, et al.
Dialogues in Clinical Neuroscience (2017) Vol. 19, Iss. 3, pp. 309-316
Open Access | Times Cited: 210
Focus on cannabinoids and synthetic cannabinoids
Reynald Le Boisselier, João Alexandre, Véronique Lelong‐Boulouard, et al.
Clinical Pharmacology & Therapeutics (2016) Vol. 101, Iss. 2, pp. 220-229
Closed Access | Times Cited: 150
E-cigarettes—An unintended illicit drug delivery system
Andreas K. Breitbarth, Jody Morgan, Alison L Jones
Drug and Alcohol Dependence (2018) Vol. 192, pp. 98-111
Open Access | Times Cited: 111
The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review
Koby Cohen, Aviv Weinstein
Brain Sciences (2018) Vol. 8, Iss. 3, pp. 40-40
Open Access | Times Cited: 109
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances
Stefania Chiappini, Giorgia Vaccaro, Alessio Mosca, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105691-105691
Open Access | Times Cited: 15
The Resurgence of Synthetic Cannabinoid Receptor Agonists as Adulterants in the Era of Cannabis Legalization: Lessons from Prior Epidemics and Clinical Implications
Aaron P. Jones, Ali S. Taha, Grover P. Miller
Neuroscience & Biobehavioral Reviews (2025), pp. 106043-106043
Closed Access | Times Cited: 1
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
Noreen Dadirai Mdege, Nick Meader, Charlie Lloyd, et al.
Public Health Research (2017) Vol. 5, Iss. 4, pp. 1-138
Open Access | Times Cited: 65
Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA
Maren Hermanns‐Clausen, Dieter Müller, Josephine Kithinji, et al.
Clinical Toxicology (2017) Vol. 56, Iss. 6, pp. 404-411
Closed Access | Times Cited: 62
The Synthetic Cannabinoids Phenomenon
Laurent Karila, Amine Benyamina, Lisa Blecha, et al.
Current Pharmaceutical Design (2016) Vol. 22, Iss. 42, pp. 6420-6425
Closed Access | Times Cited: 51
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice
Timothy W. Lefever, Julie A. Marusich, Brian F. Thomas, et al.
Substance Abuse Research and Treatment (2017) Vol. 11
Open Access | Times Cited: 43
The impacts of paper properties on matrix effects during paper spray mass spectrometry analysis of prescription drugs, fentanyl and synthetic cannabinoids
Brandon J. Bills, Jeffrey Kinkade, Greta Ren, et al.
Forensic Chemistry (2018) Vol. 11, pp. 15-22
Closed Access | Times Cited: 40
Clinical and Public Health Challenge of Handling Synthetic Cathinone and Cannabinoid Abuse in Pediatric Care: A Narrative Review
Valerio Ricci, Giuseppe Maina
Pediatric Reports (2025) Vol. 17, Iss. 1, pp. 19-19
Open Access
Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids — Anchorage, Alaska, 2015–2016
Yuri P. Springer, Roy Gerona, Erich Scheunemann, et al.
MMWR Morbidity and Mortality Weekly Report (2016) Vol. 65, Iss. 40, pp. 1108-1111
Open Access | Times Cited: 38
Sexual Orientation Disparities in the Use of Emerging Drugs
Jeremy T. Goldbach, Ethan H. Mereish, Claire Burgess
Substance Use & Misuse (2016) Vol. 52, Iss. 2, pp. 265-271
Closed Access | Times Cited: 37
Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility
David D. Aguilar, Andrea Giuffrida, Daniel J. Lodge
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 4, pp. 393-403
Open Access | Times Cited: 27
Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility
Koby Cohen, Yaniv Mama, Paola Rosca, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 22
First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone
Aaron J. Roberto, Aileen Lorenzo, Kevin J. Li, et al.
Case Reports in Psychiatry (2016) Vol. 2016, pp. 1-4
Open Access | Times Cited: 21
Methyl (S)-2-(1–7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography–tandem mass spectrometry)
Paweł Szpot, Karolina Nowak, Olga Wachełko, et al.
Forensic Toxicology (2022) Vol. 41, Iss. 1, pp. 47-58
Closed Access | Times Cited: 12
New psychoactive substances as drugs of abuse: the situation in Spain
Miguel Galícia
Emergencias (2024)
Open Access | Times Cited: 2
Prevalence of Use of Electronic Nicotine Delivery Systems (ENDS) to Vape Recreational Drugs by Club Patrons in South London
Natalie Thurtle, Rachelle Abouchedid, John R. H. Archer, et al.
Journal of Medical Toxicology (2016) Vol. 13, Iss. 1, pp. 61-65
Open Access | Times Cited: 19
Investigation of DNA damage, oxidative stress, and inflammation in synthetic cannabinoid users
Eray Metin Güler, Muhammed Yunus Bektay, AG Akyildiz, et al.
Human & Experimental Toxicology (2020) Vol. 39, Iss. 11, pp. 1454-1462
Closed Access | Times Cited: 16
Clinical and financial implications of emergency department visits for synthetic marijuana
Eric Rowley, David Benson, Aaron Tiffee, et al.
The American Journal of Emergency Medicine (2017) Vol. 35, Iss. 10, pp. 1506-1509
Closed Access | Times Cited: 17
Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication
Franziska Gaunitz, Sabrina Lehmann, Andreas Thomas, et al.
International Journal of Legal Medicine (2018) Vol. 132, Iss. 6, pp. 1645-1657
Closed Access | Times Cited: 16
Novel Psychoactive Substances and Trends of Abuse
Jessica Rivera, Emily Green Vance, William Rushton, et al.
Critical Care Nursing Quarterly (2017) Vol. 40, Iss. 4, pp. 374-382
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top